XML 90 R63.htm IDEA: XBRL DOCUMENT
v3.22.2

Subsequent Events - Additional Information (Detail) - USD ($) |  |  | 3 Months Ended |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Apr. 26, 2022 | Jan. 18, 2022 | Mar. 31, 2022 | Jun. 01, 2022 | Apr. 20, 2022 | Jan. 17, 2022 | Dec. 31, 2021 | Mar. 02, 2021 | Dec. 31, 2020
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Amount drew under the note |  |  | $ 20,000,000 |  |  |  |  |  |
Capital Unit, Class B [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Limited Partners' Capital Account, Units Authorized |  |  | 50,000,000 |  |  | 50,000,000 | 10,000,000 |  |
Limited Partners' Capital Account, Units Issued |  |  | 17,354,894 |  |  |  | 7,767,122 |  | 7,767,122
Promissory Note [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Debt Instrument, Face Amount |  | $ 100,000,000 |  |  |  |  |  |  |
PIPE Investors [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, number of shares issued in transaction |  | 57,500,000 |  |  |  |  |  |  |
Sale of stock price per share |  | $ 10 |  |  |  |  |  |  |
Sale of stock, consideration received on transaction |  | $ 575,000,000 |  |  |  |  |  |  |
Existing Directors, Officers And Equityholders Of, Or Investment Funds Managed By Suvretta Capital Management, LLC [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, consideration received on transaction |  | 156,400,000 |  |  |  |  |  |  |
Existing Directors, Officers And Unitholders Of ProKidney [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, consideration received on transaction |  | 50,000,000 |  |  |  |  |  |  |
Existing Directors, Officers And Unitholders Of ProKidney [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, consideration received on transaction |  | 100,000,000 |  |  |  |  |  |  |
Subsequent Event [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Line of Credit Facility, Maximum Borrowing Capacity |  | $ 100,000,000,000 |  |  |  |  |  |  |
Line of Credit Facility, Current Borrowing Capacity |  |  |  |  |  |  | $ 20,000,000,000 |  |
Subsequent Event [Member] | Capital Unit, Class B [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Limited Partners' Capital Account, Units Authorized |  |  |  |  |  | 50,000,000 |  |  |
Subsequent Event [Member] | Capital Unit Class B 1 [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Limited Partners' Capital Account, Units Issued |  |  |  | 549,451 |  | 8,848,901 |  |  |
Capital Units, Value |  |  |  | $ 500,000,000 |  | $ 8,052,000,000 |  |  |
Subsequent Event [Member] | Capital Unit Class B 1 [Member] | Deferred Profit Sharing [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Limited Partners' Capital Account, Units Issued |  |  |  | 1,478,590 |  | 8,498,488 |  |  |
Restricted Stock Rights [Member] | ProKidney LP [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Business acquisition, equity interest issued or issuable, number of shares |  | 17,500,000 |  |  |  |  |  |  |
Restricted Stock Rights [Member] | ProKidney LP [Member] | Share Price One [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Business acquisition, share price |  | $ 15 |  |  |  |  |  |  |
Restricted Stock Rights [Member] | ProKidney LP [Member] | Share Price Two [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Business acquisition, share price |  | 20 |  |  |  |  |  |  |
Restricted Stock Rights [Member] | ProKidney LP [Member] | Share Price Three [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Business acquisition, share price |  | $ 25 |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | PIPE Investors [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, number of shares issued in transaction |  | 57,500,000 |  |  |  |  |  |  |
Sale of stock price per share |  | $ 10 |  |  |  |  |  |  |
Sale of stock, consideration received on transaction |  | $ 575,000,000 |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | Existing Directors, Officers And Equityholders Of, Or Investment Funds Managed By Suvretta Capital Management, LLC [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, consideration received on transaction |  | 156,400,000 |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | Existing Directors, Officers And Unitholders Of ProKidney [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, consideration received on transaction |  | 50,000,000 |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | Existing Directors, Officers And Unitholders Of ProKidney [Member] | Maximum [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Sale of stock, consideration received on transaction |  | $ 100,000,000 |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | Sponsor [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Debt Instrument, Face Amount |  |  |  |  |  |  |  | $ 300,000 |
Social Capital Suvretta Holdings Corp. III [Member] | Sponsor [Member] | Promissory Note [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Debt Instrument, Face Amount |  |  |  |  |  |  |  | $ 300,000 |
Social Capital Suvretta Holdings Corp. III [Member] | Subsequent Event [Member] | Sponsor [Member] | Promissory Note [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Debt Instrument, Face Amount |  |  |  |  | $ 1,500,000 |  |  |  |
Amount drew under the note | $ 250,000 |  |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | Restricted Stock Rights [Member] | ProKidney LP [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Business acquisition, equity interest issued or issuable, number of shares |  | 17,500,000 |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | Restricted Stock Rights [Member] | ProKidney LP [Member] | Share Price One [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Business acquisition, share price |  | $ 15 |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | Restricted Stock Rights [Member] | ProKidney LP [Member] | Share Price Two [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Business acquisition, share price |  | 20 |  |  |  |  |  |  |
Social Capital Suvretta Holdings Corp. III [Member] | Restricted Stock Rights [Member] | ProKidney LP [Member] | Share Price Three [Member] |  |  |  |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |  |  |  |
Business acquisition, share price |  | $ 25 |  |  |  |  |  |  |

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(4) -URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionSharePrice
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Value of capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04.16(a)) -URI https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996 + Details
Name: | us-gaap_CapitalUnits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Face (par) amount of debt instrument at time of issuance. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69C -URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69B -URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612 + Details
Name: | us-gaap_DebtInstrumentFaceAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of limited partner units authorized to be issued. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 5 -Subparagraph (SAB Topic 4.F) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770 + Details
Name: | us-gaap_LimitedPartnersCapitalAccountUnitsAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of limited partner units issued. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 5 -Subparagraph (SAB Topic 4.F) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770 + Details
Name: | us-gaap_LimitedPartnersCapitalAccountUnitsIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromRelatedPartyDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References No definition available. + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CapitalUnitsByClassAxis=us-gaap_CapitalUnitClassBMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=prok_PromissoryNoteMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=prok_PipeInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=prok_ExistingDirectorsOfficersAndEquityholdersOfOrInvestmentFundsManagedBySuvrettaCapitalManagementLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=prok_ExistingDirectorsOfficersAndUnitholdersOfProkidneyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CapitalUnitsByClassAxis=prok_CapitalUnitClassBOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis=us-gaap_DeferredProfitSharingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=prok_RestrictedStockRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=prok_ProkidneyLpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | prok_SharePriceRangeAxis=prok_SharePriceOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | prok_SharePriceRangeAxis=prok_SharePriceTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | prok_SharePriceRangeAxis=prok_SharePriceThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=prok_SocialCapitalSuvrettaHoldingsCorp.IiiMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=prok_SponsorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |